Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director,

Slides:



Advertisements
Similar presentations
Chronic Kidney Disease/Dialysis Belinda Jim, MD January 15, 2009.
Advertisements

Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
The PREVEND Study: Screening for micro-albuminuria
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Proteinuria as a Surrogate Outcome in Chronic Kidney Disease Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson,
CKD In Primary Care Dr Mohammed Javid.
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Managing Chronic Kidney Disease in the Elderly Veteran Ann M. O’Hare, MA MD Staff Physician, VAPSHCS Assistant Professor of Medicine University of Washington.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Stages of CKD – KDOQI 2002 Definitions
Lesley Stevens MD Tufts-New England Medical Center
THE NKF-KDOQI (2002) CKD DEFINITION AND CLASSIFICATION SYSTEM: Limitations and Problems Richard J. Glassock, MD, MACP David Geffen School of Medicine at.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Change in prevalence of Chronic Kidney Disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Estimated GFR Based on Creatinine and Cystatin C
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
Health Care Costs Associated with Chronic Kidney Disease in Patients with Type II Diabetes Zita Shiue, MD Internal Medicine, R3 Chief of Medicine Conference.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND RENAL FUNCTION. WHAT'S THE ROLE OF INFLAMMATION? Marquis Hawkins, Ph.D. Postdoctoral Scholar University.
... Assessing renal function in the elderly The development of a new Iohexol based method to measure the true Glomerular Filtration Rate Gijs Van Pottelbergh,
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Section 2: Detection of CKD. What Tests Are Available? Direct GFR measurement –Inulin clearance –Radionuclides –Iohexol clearance 3 hr CrCl with Cimetidine.
HIV/renal studies (CHIC) Baseline renal function as predictor of HIV/renal disease progression –Death, opportunistic infection –Severe chronic kidney disease.
Proteinuria as a surrogate outcome in CKD UKPDS Rudy Bilous Middlesbrough, UK.
Dick de Zeeuw Department of Clinical Pharmacology University Medical Center Groningen The Netherlands Albuminuria; a tool for measuring non-blood pressure.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Epidemiology of Anaemia in CKD
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Predicting Progression in Diabetic Nephropathy: New Biomarker: sTNFR1* Circulating soluble Tumor Necrosis Factor Receptor 1.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Optimum Re 2015 Charlotte A. Lee, M.D., FLIM, DBIM EVALUATING RENAL FUNCTION.
1 به نام خدا. Epidemiology of chronic kidney disease 2.
Professor Tazeen H Jafar Duke-National University of Singapore & Aga Khan University, Karachi, Pakistan Chronic Kidney Disease- Integration into the NCD.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
Prevalence of Chronic Kidney Disease in an Urban Population
내과 R1 문정락 / prof. 정경환 N Engl J Med 369;10 nejm.org 932 september 5, 2013.
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Independent Components of Chronic Kidney Disease.
Stephen R. Ash, MD, FACP IU Health Arnett Lafayette, Indiana 2017
Section 2: Detection of CKD
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Section 4: Managing progression of CKD
Chapter 1: CKD in the General Population
Volume 80, Issue 1, Pages (July 2011)
Estimated GFR in Diabetes
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
The percentage of subjects with de novo development of renal function impairment (GFR
Volume 67, Issue 6, Pages (June 2005)
Volume 80, Issue 1, Pages (July 2011)
Management of hypertension in patients with chronic kidney disease
Chapter 1: CKD in the General Population
GFR Estimation: From Physiology to Public Health
Meeting the challenges of the new K/DOQI guidelines
American Journal of Kidney Diseases
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Presentation transcript:

Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director, Cardiovascular Epidemiology Program Welch Center Departments of Epidemiology, Medicine & Biostatistics Johns Hopkins University Disclosures: None Proteinuria as a Surrogate Outcome in Chronic Kidney Disease A workshop co-sponsored by the National Kidney Foundation and U.S. Food and Drug Administration

Outline CKD prevalence –Albuminuria by stage & its persistence CVD risk in relation to: –Albuminuria and eGFR Creatinine (eGFR MDRD ) Cystatin C (eGFR CysC ) Conclusions

Prevalence of CKD: NHANES Surveys Representing the US Adult Population Study Population: stratified random sample –NHANES III (1988 to 1994): n=15,488* –NHANES : n=4,101* –NHANES : n=4,684 –NHANES : n=4,448 Serum creatinine: calibrated to be comparable to the MDRD creatinine assay using frozen serum (Am J Kidney Dis. 2007;50:918-26) GFR Estimate: MDRD Study 4-variable equation Extrapolation to US population: NCHS published survey weights adjusting for age, sex, race and non-response *Coresh et al. JAMA. 2007; 298(17):

Distribution of Albumin to Creatinine Ratio: NHANES Albumin to Creatinine Ration, mg/g micro ”normal” macro

Prevalence of Diagnosed Diabetes and Hypertension by Albuminuria: NHANES < ACR mg/g Proportion Prevalence Age, y 41% (9,920) 50% (13,000) 7.1% (2648) 1.2% (573)

CKD Prevalence Estimates Require GFR Estimation (eGFR) MDRD Study Equation (GFR ml/min/1.73m 2 ) eGFR = 186 x (SCr) x (age) x (0.742 if female) x (1.210 if African American) eGFR = 175 x (Standardized SCr) x (age) x (0.742 if female) x (1.210 if African American) Cockcroft-Gault (CG ml/min) Ccr = (140-age) x weight x 0.85 (if female)/(SCr) BSA Adjusted = CG * 1.73 / BSA formula Equations in other populations –Children, Chinese, Japanese, Kidney Donors N Engl J Med. 2006; 354(23): Clin Chem 2007; 53(4):766-72

Estimated GFR Distribution The conservative trends analysis eliminated the difference in mean GFR between surveys. The vertical line demarcates an estimated GFR of 60 ml/min/1.73m 2 which defines decreased GFR. Estimated GFR, ml/min/1.73m 2

Relationship of eGFR to Albuminuria & Hypertension: NHANES III Am J Kidney Dis 2002;39:(2) S49 Albuminuria only Normal High BP only Albuminuria & High BP

Chronic Kidney Disease (CKD) Definition Kidney damage for 3+ months as defined by structural of functional abnormalities of the kidney, with or without decreased GFR manifest by either: –Pathological abnormalities, or –Markers of kidney damage including abnormalities in the composition of the blood or urine, or abnormalities in imaging tests GFR < 60 ml/min/1.73m 2 for 3+ months with or without kidney damage Am J Kidney Dis 2002;39:(2) S1-S266 Ann Intern Med 2003; 139(2):

Log(ACR) – Second Visit Log(ACR) – First Visit Macro >300 mg/g Micro mg/g Macro >300 mg/g Micro mg/g “Normal” Persistence of Albuminuria – Spot Urine ACR in 2 visits a median of 17 days apart: NHANES III

Persistence of Albuminuria: NHANES III Albuminuria at First Visit,mg/g Albuminuria on a Repeat Visit (median 17 days later) eGFR 90+eGFR <90 Micro, *50.9% (n=57) 75.0% (n=36) Macro % * 53.9% and 72.7% for gender specific cutoffs for micro- albuminuria mg/g for men and mg/g for women

US Trends in the Prevalence of CKD by Age and Stage: NHANES Coresh et al. JAMA. 2007;298: % 10% 20% 30% 40% 50% Age Group: Prevalence, % Stage 4 Stage 3 Stage 2 Stage 1 CKD Stage Survey years: Persistent albuminuria >30 mg/g eGFR MDRD eGFR MDRD 30-59

Prevalence of Elevated Cystatin C in US Women (>1.12 mg/L = 99 th %ile for young healthy adults) Women 0% 20% 40% 60% 80% 100% Proportion with cystatin C >1.12 mg/L Age(years) non-Hispanic white non-Hispanic black Mexican American Kottgen et al. Am J Kidney Dis 2008;51: (n=7,596)

Different Outcomes of CKD OutcomeImportance for Different Outcomes CKD StageType of Kidney Disease (Diagnosis)** Proteinuria Concurrent complications* Prognosis (next 10-years) Risk of CVD or mortality Risk of kidney failure Rate of decline in GFR ++++ *Hypertension, anemia, malnutrition, bone disease, neuropathy & decreased quality of life **For example, diabetic, glomerular, vascular, tubulointerstitial, & cystic

Albuminuria and Risk of Cardiovascular Death General Population: Risk Seen at Very Low Levels PREVEND Study - Hillege HL et al, Circulation 2002;106: Micro- albuminuria Urinary Albumin Concentration mg/day Hazard Ratio 20 mg/day (30 mg/g) 200 mg/day (300 mg/g)

CKD and Risk of Death: Kaiser Permanente Study Go et al. N Engl J Med 2004;351: Also showed adjusted excess risk for: - Mortality - CVD events - Hospitalizations

Risk of Death among Elderly Persons: CHS Study Mean Age 74 Years Shlipak et al. N Engl J Med 2005;352: Quintile a Decreased Kidney Function

Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population (Astor et al. Am J Epidemiol 2008, April ePUB)

Cardiovascular Mortality Models adjusted to incidence rates of a 60-year-old non-Hispanic White male.

All-Cause Mortality Models adjusted to incidence rates of a 60-year-old non-Hispanic White male.

Adjusted* Cardiovascular Mortality Risk by eGFR and albuminuria *adjusted to the incidence rates of a 60 year-old, non-Hispanic white male. Astor et al. Am J Epidemiol 2008; April

Cardiovascular mortality in NHANES III F/U Predicted incidence rates adjusted to the mortality rate of a 60 year ‑ old, non-Hispanic white male Astor et al. Am J Epidemiol 2008; April

All-Cause mortality in NHANES III F/U Predicted incidence rates adjusted to the mortality rate of a 60 year ‑ old, non-Hispanic white male Astor et al. Am J Epidemiol 2008; April

Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study Hallan et al. Arch Intern Med. 2007;167(22): eGFR ml/min/1.73m 2 ACR, mg/g Age & Sex Adjusted IRR ACR – average 3 spot urines Optimal < median Men: < 5 Women: < 7 High normal Men: 5 to 19 Women: 7 to 29 Microalbuminuria Men: 20 to 199 Women: 30 to

Cardiovascular Mortality by eGFR and Albuminuria: HUNT II Study Hallan et al. Arch Intern Med. 2007;167(22): Albuminuria, mg/g (average of 3 spot urines) ACR Optimal < median Men: < 5 Women: < 7 High normal Men: 5 to 19 Women: 7 to 29 Microalbuminuria Men: 20 to 199 Women: 30 to 299 *P.05. †P.01. ‡P.001.

Adjusted Annual Cardiovascular Mortality (%) Estimated GFR (mL/min/1.73m 2 ) Adjusted* Cardiovascular Mortality Risk in NHANES III Mortality Follow-Up Study Astor et al. JASN 2007 abstract High eGFR MDRD  low muscle mass (BAD) *Adjusted for 13 covariates eGFR MDRD eGFR CysC Age > 65 Age ≤ 65

*Adjusted to the age of 60 years, female, Whites, HD and non-smokers. Overall Distorted Associations (Baseline Disease  RF  CVD) Adjusted* 3-year all-cause mortality in Dialysis Patients Presence of Inflammation/Malnutrition Absence of Inflammation/Malnutrition

Distorted Associations (Baseline Disease  RF  CVD) Adjusted* 3-year all-cause mortality in Dialysis Patients *Adjusted to the age of 60 years, female, Whites, HD and non-smokers. Overall Presence of Inflammation/Malnutrition Absence of Inflammation/Malnutrition JAMA 2004;291:

Conclusions Albuminuria is common in the population –Spot ACR provides a reasonable measure –Cutoffs are somewhat arbitrary: sex dependent cutoffs are more accurate but non-sex dependent cutoff are useful & less complicated –Microalbuminuria varies within an individual – persistence is a useful indicator –Much more common among diabetics; but a substantial proportion of the individuals with microalbuminuria have neither hypertension nor diabetes Albuminuria and eGFR are associated but confer independent risk (mortality, CVD mortality)

Thank you! CKD-Epi ARIC Staff CHOICE Study CVD-EpiStein Hallan